Therapeutic effect of thalidomide through cytokine and chemokine regulation in herpes simplex virus-induced Behçet's disease-like animal model

Adv Exp Med Biol. 2003:528:585-9. doi: 10.1007/0-306-48382-3_119.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Behcet Syndrome / drug therapy*
  • Behcet Syndrome / immunology*
  • Behcet Syndrome / virology
  • Chemokine CCL4
  • Chemokines / immunology*
  • Cytokines / drug effects
  • Cytokines / immunology*
  • Disease Models, Animal
  • Gene Expression Regulation / drug effects
  • Herpes Simplex / complications*
  • Macrophage Inflammatory Proteins / genetics
  • Male
  • Membrane Glycoproteins / genetics
  • Mice
  • Mice, Inbred ICR
  • Perforin
  • Pore Forming Cytotoxic Proteins
  • RNA, Messenger / genetics
  • Thalidomide / therapeutic use*
  • Tumor Necrosis Factor-alpha / genetics

Substances

  • Chemokine CCL4
  • Chemokines
  • Cytokines
  • Macrophage Inflammatory Proteins
  • Membrane Glycoproteins
  • Pore Forming Cytotoxic Proteins
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • Perforin
  • Thalidomide